Ocarina I
Research payments
$8,453,826
Through program year 2025, $8,453,826 in research payments was reported against Ocarina I, across 742 payments.
- Paid by (largest first)
- Genentech, Inc.; F. Hoffmann-La Roche AG; Hoffmann-La Roche Limited
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $704,640 | 116 |
| 2024 | Research | $1,383,594 | 181 |
| 2023 | Research | $912,977 | 123 |
| 2022 | Research | $1,259,023 | 115 |
| 2021 | Research | $2,388,278 | 118 |
| 2020 | Research | $1,648,217 | 78 |
| 2019 | Research | $157,098 | 11 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
6 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.